Cargando…
Do telomerase antagonists represent a novel anti-cancer strategy?
Autor principal: | Parkinson, E. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074295/ https://www.ncbi.nlm.nih.gov/pubmed/8554968 |
Ejemplares similares
-
Perifosine as a potential novel anti-telomerase therapy
por: Holohan, Brody, et al.
Publicado: (2015) -
Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton
por: MENDER, ILGEN, et al.
Publicado: (2013) -
Anti-Cancer Immunotherapies Targeting Telomerase
por: Negrini, Simone, et al.
Publicado: (2020) -
A novel telomerase substrate precursor rapidly induces telomere dysfunction in telomerase positive cancer cells but not telomerase silent normal cells
por: Mender, Ilgen, et al.
Publicado: (2015) -
Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma
por: Wu, Xuping, et al.
Publicado: (2017)